Skip to main content

and
  1. No Access

    Protocol

    Discovery of Covalent Drugs Targeting the Key Enzymes of SARS-CoV-2 Using SCARdock

    Historically, covalent drugs were avoided in drug development process due to the possible toxicity linked to the covalent binding of such drugs and cellular proteins. However, recent years have witnessed the f...

    Qi Song, Zhiying Wang, Sen Liu in In Silico Modeling of Drugs Against Coronaviruses (2021)